Company Overview

Nephrogen is a San Francisco-based preclinical biotech company developing curative gene therapies for kidney diseases, starting with polycystic kidney disease (PKD) that affects 600,000 Americans, using AI-driven drug discovery and genetic engineering. The Y Combinator-backed company (W20) has raised $775K to date and is currently raising a $4M seed round, supported by investors including StartX and 2048 Ventures, plus a $325K NIH grant. Nephrogen distinguishes itself by combining AI, gene therapy, and nephrology to deliver curative rather than palliative treatments for significant unmet needs in kidney disease.

Loading News...
Loading Timeline...
Loading Culture...
Loading Leadership...

Open Positions

Reddit Discussions

Loading Competitive Intelligence...

Key Differentiators

Emerging Innovator

Nephrogen is an emerging player bringing innovative solutions to the Healthcare market.

Frequently Asked Questions

AI Visibility Rankings

How Nephrogen performs in AI search results

AI Rank
?
Track your position
Platforms
5
ChatGPT, Gemini, Claude...
Visibility
?
Your mention rate
Premium Feature

Unlock AI Visibility Tracking for Nephrogen

See exactly how Nephrogen ranks across ChatGPT, Gemini, Perplexity, Claude, and Grok. Get actionable insights to improve your AI search performance.

Real-time Rankings
Track your position daily
Competitive Intel
See how you compare
Platform Breakdown
Per-AI performance
Actionable Insights
Optimize your visibility
Start Tracking for Free

Join 1,000+ brands · Free 7-day trial · No credit card required

Want to improve your AI visibility? Track performance across all major AI platforms.
Compare with Other Brands

Not So Random Others

Compare with Other Brands

See how Nephrogen stacks up against competitors with our detailed comparison tool.

Start Comparison